Anticoagulation and Survival in Pulmonary Arterial Hypertension: Results From the COMPERA Registry

Study Questions:

Despite limited evidence, anticoagulation has been recommended for patients with idiopathic pulmonary arterial hypertension (IPAH) since the 1990s. Is anticoagulation justified in IPAH in the modern management era, and should it be extended to patients with other forms of pulmonary arterial hypertension (PAH)?